Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings - Wikidata - awgldk - TriplyDB

Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings

Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings

http://www.wikidata.org/entity/Q36626050

about

Quantitative imaging in cancer evolution and ecology Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma.The usefulness of standardized uptake value in differentiation between benign and malignant thyroid lesions detected incidentally in 18F-FDG PET/CT examination.Quantitative imaging biomarkers: a review of statistical methods for computer algorithm comparisons.Utility of 18F-FDG PET with a semi-quantitative index in the detection of sarcomatous transformation in patients with neurofibromatosis type 1.Reproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR Test-Retest Variability in Lesion SUV and Lesion SUR in 18F-FDG PET: An Analysis of Data from Two Prospective Multicenter Trials.Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.Variability of Image Features Computed from Conventional and Respiratory-Gated PET/CT Images of Lung Cancer.Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size.Value of volume-based metabolic parameters for predicting survival in breast cancer patients treated with neoadjuvant chemotherapy.Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volume.Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization.Evaluation of Cross-Calibrated 68Ge/68Ga Phantoms for Assessing PET/CT Measurement Bias in Oncology Imaging for Single- and Multicenter Trials Qualification of National Cancer Institute-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials.Repeatability of SUV in Oncologic 18F-FDG PET.Longitudinal monitoring of reconstructed activity concentration on a clinical time-of-flight PET/CT scanner.Sensitivity of Image Features to Noise in Conventional and Respiratory-Gated PET/CT Images of Lung Cancer: Uncorrelated Noise Effects.Variation and repeatability of measured standardized uptake values depending on actual values: a phantom study.Quantitation of Cancer Treatment Response by 18F-FDG PET/CT: Multicenter Assessment of Measurement Variability.Multicenter survey of PET/CT protocol parameters that affect standardized uptake values.Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis.Prognostic evaluation of percentage variation of metabolic tumor burden calculated by dual-phase (18) FDG PET-CT imaging in patients with head and neck cancer.An account of data entry inconsistencies and their impact on positron emission tomography quantification

P2860

Q27016021-E110F16B-9E40-41CD-8BFD-DFD63E39808E Q33780956-D2B3844A-C4E3-47BE-BFA4-CACF6B2E33DF Q34309266-D694F268-6383-475A-B7CF-ACB58664AE41 Q34681714-CF0303FB-8C84-4208-A901-B1788A0FE267 Q35091332-87B1CDA4-0A3C-42C1-9BBF-C393B163679B Q36295389-34905D65-7994-4730-94BC-D04AA47C32A8 Q36363737-703E2159-E667-4248-BE4D-D434F8A28259 Q36425061-A0C3D0A2-8DA2-4BA5-87FC-971EBD9D0BD7 Q36427534-BDF1DB05-9B5D-49F1-9E6E-3D13046BB567 Q36567875-5567D74C-CE3C-4904-81F3-74B8214BAFDF Q37354718-A5C8A7EB-0198-452D-8AFA-CC9FE35E47AF Q37495153-5A17C3F7-F160-4E47-8F71-3C35BE940475 Q37522674-4EADECE4-E78D-47FB-81A7-2F0FB7D8A1AD Q37558197-096B17AA-8F21-4398-875D-88E4F006B94D Q38932290-B6609E9C-697B-4901-AAC4-97C4CCA3890B Q38945159-36B7B7CF-0FE8-4514-B267-98BDF0437BDC Q39127862-17492989-8BF2-456D-8038-0B02C8331CE1 Q45938612-216B649D-197C-40CC-A443-208AB02CFE4D Q47142206-891B7BBE-4699-4D24-9265-5B2B5D83E13F Q48673112-E7D5D409-BB86-4169-B0B6-389401BF44E0 Q49694520-DD46EE9B-8529-47FC-A3ED-03CDC8C1CA57 Q49836052-923BAFCB-7A31-475C-8537-0A178F721839 Q53020730-56160E3E-7836-4212-96B4-AFCCD5BCF791 Q58739579-F096F763-7AFF-469E-8613-496C3395FAE2

P2860

Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings

http://www.wikidata.org/entity/Q36626050

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Variance of SUVs for FDG-PET/C ...... han under ideal study settings

@ast

Variance of SUVs for FDG-PET/C ...... han under ideal study settings

@en

type

label

Variance of SUVs for FDG-PET/C ...... han under ideal study settings

@ast

Variance of SUVs for FDG-PET/C ...... han under ideal study settings

@en

prefLabel

Variance of SUVs for FDG-PET/C ...... han under ideal study settings

@ast

Variance of SUVs for FDG-PET/C ...... han under ideal study settings

@en

P1433

Q36626050-7BB0D20A-AFEC-4F88-91D7-25BFFD393B65

P1476

Q36626050-8B13B4A1-586A-4FB0-87A8-DCB8B80077CC

P2093

Q36626050-12ED095D-7363-42AD-A773-D2E96F7B997A

Q36626050-26E28451-870B-4FF8-A349-0E175A7FA094

Q36626050-43625580-2CAF-459A-85DF-6B4A1100826B

Q36626050-7F060530-1215-415A-9219-3CBA42CF52CE

Q36626050-8FD82928-6134-4BAF-B93B-79508B2316E6

Q36626050-AF0097F7-BB8A-451F-899C-3E7EDE563DDC

Q36626050-ED60C8E2-BFB6-402E-BC51-9C4C0CF0F07A

P2860

Q36626050-0AFD139A-0731-4C30-BECA-1A4ABA5D9B1A

Q36626050-18683261-3CE0-4769-984B-65B5D26D587C

Q36626050-19F0AB8A-CF4B-4E76-861E-BEEA38D08986

Q36626050-1D45D7CF-C394-4832-84A7-6FC062A24363

Q36626050-1D618B20-0BED-424B-A5B8-D7759B315284

Q36626050-1F413EA2-2765-4392-B543-AAB0DFC9473C

Q36626050-24D24DA9-93F0-426D-9F6B-2E99DF52D88F

Q36626050-2718FB10-5B99-4D7D-90C5-7E243A064B06

Q36626050-2B4A2124-854E-45EC-91DA-B6B64F56DFB8

Q36626050-2D3D9FEF-5BB0-4392-BC88-C90D9EE2A06C

P304

Q36626050-D68CE762-73D3-4C84-8353-823E4DFF9BAF

P31

Q36626050-2B6C58E3-084C-4DFF-A3BC-18CB93C1B1E3

P356

Q36626050-64697439-57A7-4541-84F9-7D43AA2B0394

P433

Q36626050-3852E373-0A9E-4E19-9CF0-4E477C090BAF

P478

Q36626050-E6CF7FA6-2450-474B-B55C-7C5A064726A5

P50

Q36626050-4CD1ED2A-1593-404B-A9E8-A702F2492DB6

Q36626050-DBB4793D-A679-4D98-B8F1-FF9CBD655907

P577

Q36626050-5CC3A710-5989-498C-9271-E54D6D301FB3

P698

Q36626050-77522181-43C4-4FF0-B9F6-3828266850DD

P932

Q36626050-B3B486CB-FAF6-417C-A524-E33E42ED68FB

P356

RLU.0B013E318279FFDF

P1433

Clinical Nuclear Medicine

P1476

Variance of SUVs for FDG-PET/C ...... han under ideal study settings

@en

P2093

Alberto A Chiappori

http://www.w3.org/2001/XMLSchema#string

Claudia G Berman

http://www.w3.org/2001/XMLSchema#string

Edward A Eikman

http://www.w3.org/2001/XMLSchema#string

Jongphil Kim

http://www.w3.org/2001/XMLSchema#string

Kavindra Nath

http://www.w3.org/2001/XMLSchema#string

Robert A Gatenby

http://www.w3.org/2001/XMLSchema#string

Tawee Tanvetyanon

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection

PET/CT: form and function.

Imaging as a quantitative science.

Quantitative imaging to assess tumor response to therapy: common themes of measurement, truth data, and error sources

PET/CT Assessment of Response to Therapy: Tumor Change Measurement, Truth Data, and Error.

Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer.

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

Variability in PET quantitation within a multicenter consortium.

Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT.

P304

175-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/RLU.0B013E318279FFDF

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Robert J Gillies

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23354032

http://www.w3.org/2001/XMLSchema#string

P932

3578161

http://www.w3.org/2001/XMLSchema#string